Bz-Gly-His-Leu

Bz-Gly-His-Leu is a synthetic peptide composed of benzoyl-protected glycine, histidine, and leucine residues, designed for advanced biochemical research and peptide science applications. As a tripeptide featuring both aromatic and aliphatic side chains, it offers a unique structural motif relevant to studies in protease specificity, peptide-receptor interactions, and enzymatic catalysis. Its defined sequence and chemical stability make it a reliable substrate or probe for investigating peptide processing, structure-activity relationships, and the underlying mechanisms of protein function in vitro. The presence of the benzoyl group at the N-terminus further enhances its utility in experimental systems requiring protected or modified peptides, supporting a broad range of analytical and synthetic workflows.

Protease substrate studies: In enzymology research, Bz-Gly-His-Leu serves as a valuable model substrate for assessing the specificity and activity of various proteases, including serine and metalloproteases. The benzoyl group at the N-terminus renders the peptide resistant to certain exopeptidases while remaining susceptible to endopeptidase cleavage at defined positions, allowing researchers to dissect enzyme-substrate recognition and cleavage kinetics. Utilizing this peptide in proteolytic assays can help elucidate the substrate preferences of target enzymes, inform inhibitor design, and facilitate the development of high-throughput screening protocols for enzyme modulators.

Peptide structure-activity relationship analysis: The defined sequence and chemical modifications of this tripeptide make it a useful tool for probing the relationship between peptide structure and biological activity. By incorporating Bz-Gly-His-Leu into systematic libraries or analog series, researchers can investigate how variations in residue composition, side chain functionality, or N-terminal protection influence binding affinity, conformational stability, and interaction with biological targets. Such studies are critical for optimizing lead peptides in drug discovery pipelines, designing novel biomimetics, and advancing fundamental understanding of peptide-mediated molecular recognition.

Analytical method development: Bz-Gly-His-Leu is frequently employed as a reference standard or calibration peptide in the development and validation of analytical techniques such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and capillary electrophoresis (CE). Its well-defined mass, sequence, and chromatographic behavior make it ideal for optimizing separation conditions, calibrating detection systems, and quantifying peptide recovery or degradation during sample processing. The use of this tripeptide in analytical workflows supports accurate, reproducible peptide quantification and quality control across a range of research and industrial settings.

Peptide synthesis validation: In laboratories focused on solid-phase peptide synthesis (SPPS) and related chemistries, Bz-Gly-His-Leu is often utilized as a model sequence to evaluate coupling efficiency, deprotection protocols, and overall synthetic yield. Its moderate length and diverse side chain chemistry provide a practical challenge for optimizing resin selection, reagent choice, and purification strategies. Successful synthesis and isolation of this peptide can serve as a benchmark for method development, troubleshooting, and technology transfer in peptide manufacturing environments.

Enzyme inhibitor screening: The tripeptide structure and specific sequence of Bz-Gly-His-Leu make it a suitable substrate for use in high-throughput screening assays aimed at identifying inhibitors of peptide-processing enzymes. By monitoring the hydrolysis of this peptide in the presence of candidate compounds, researchers can rapidly assess inhibitory potency, selectivity, and mechanism of action. This application is particularly valuable in early-stage drug discovery, where robust and sensitive assays are required to evaluate large compound libraries and prioritize hits for further development.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries